AstraZeneca's Covid-19 Vaccine Gets EU Approval for Third Doses
23 Maio 2022 - 04:03AM
Dow Jones News
By Jaime Llinares Taboada
AstraZeneca PLC said Monday that its Covid-19 vaccine has been
granted approval in the European Union as a third dose booster for
adults.
The pharmaceutical company said that its Vaxzevria vaccine can
now be used as a third dose booster in patients previously given a
vaccine schedule of either Vaxzevria or other EU-approved
vaccines.
"Although more than 65% of the global population has received at
least one dose of a Covid-19 vaccine, there remains a significant
challenge to ensure people receive both their primary vaccine
schedule and third-dose booster, and healthcare professionals now
have greater flexibility in their choice of vaccine," AstraZeneca
said.
Write to Jaime Llinares Taboada at jaime.llinares@wsj.com;
@JaimeLlinaresT
(END) Dow Jones Newswires
May 23, 2022 02:48 ET (06:48 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Astrazeneca (LSE:AZN)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024
Astrazeneca (LSE:AZN)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024